HIGHLIGHTS
- who: Therapeutics and collaborators from the Zhejiang University School of Medicine, Hangzhou, China, Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang have published the article: Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction, in the Journal: (JOURNAL)
SUMMARY
The growing burden of cardiovascular disease (CVD) is emerging as a major public health issue, particularly in the context of the COVID-19 pandemic, thus presenting an alarming risk to the healthcare settings worldwide (Zhao et_al, 2019; Hessami et_al, 2021). Myocardial infarction (MI), the most severe type of CVD, is caused by the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.